Kelly Kluka

Healthcare Providers

• GTCR in its investment in Caravel Autism Health, a provider of applied behavior analysis therapy for children on the autism spectrum
• TPG's The Rise Fund in its investment in Banyan Treatment Centers, a provider of substance use disorder and mental health services
• Brookfield Special Investments in its $400 million investment in Sono Bello, a provider of laser liposuction and body contouring
• Charlesbank Capital Partners in its acquisition of Action Behavior Centers, a provider of Applied Behavior Analysis therapy, from NexPhase Capital
• Arsenal Capital Partners-backed Hopebridge in its acquisition of Autism in Motion Clinics, a provider of autism treatment

Healthcare Technology

• Francisco Partners in the investment in RedSail Technologies, a provider of pharmacy technology and solutions, from Leonard Green & Partners
• Olympus Partners in the sale of Soliant, a provider of workforce solutions in K-12 school districts and healthcare facilities, to The Vistria Group
• Bain Capital Insurance in its investment in Aptia, a provider of employee benefits and pensions administration service
• Abry Partners-backed Millennium Trust in its $775 million acquisition of PayFlex, a provider of health savings accounts (HSAs) and consumer-directed benefit administration services, from CVS Health (NYSE: CVS)
• Parthenon Capital-backed Zelis in its acquisition of Payer Compass, a provider of reimbursement and claims pricing, administration and processing solutions, from Health Equity Partners and Spectrum Equity Management
• Sheridan Capital Partners-backed SpendMend, a provider of tech-enabled solutions to optimize the cost cycle for the healthcare industry, in its sale to Morgan Stanley Capital Partners
• Envista (NYSE: NVST) in its $600 million acquisition of Carestream Dental's Scanning Technology business, which includes intraoral scanner equipment and related software
• Cinven in its acquisition of Nitel, a provider of internet connectivity and networking technology services to multi-site small and medium-sized enterprises

Life Sciences

• Altaris in its pending acquisition of Minaris Regenerative Medicine, a provider of autologous and allogeneic manufacturing services for pharmaceutical and biotech customers, from Resonac
• Eli Lilly and Company (NYSE: LLY) in its $3.2 billion acquisition of Morphic (NASDAQ: MORF), a biotechnology company
• GTCR in its pending $627 million acquisition of Surmodics (NASDAQ: SRDX), a provider of medical device and in vitro diagnostic technologies
• Waters Corp. (NYSE: WAT) in its $1.36 billion acquisition of Wyatt Technology, a provider of light scattering and field-flow fractionation instruments, software, accessories and services
• TJC in its sale of Worldwide Clinical Trials, a full service contract research organization (CRO), to Kohlberg & Company
• SK Capital in its acquisition of Apotex, a pharmaceutical company that produces affordable medicines
• Owens & Minor (NYSE: OMI) in its $1.6 billion acquisition of Apria (NASDAQ: APR), a provider of integrated home healthcare equipment and related services
• EW Healthcare Partners in its acquisition of Germfree Laboratories, a manufacturer of turnkey, mobile and modular cleanrooms and biocontainment facilities, as well as the equipment and services required for critical environments
• TA Associates in its investment in Intelerad, a provider of enterprise medical imaging solutions
• Pritzker Private Capital-backed PathGroup, a provider of anatomic, clinical, molecular and digital pathology services, in its majority investment from GTCR
• Cinven in its investment in BioAgilytix, a contract research organization that provides bioanalytical services to pharmaceutical and biotech companies

Restructuring

• Center for Autism and Related Disorders, LLC (“CARD”) and four of its affiliates in their Chapter 11 cases in the U.S. Bankruptcy Court for the Southern District of Texas. CARD is one of the nation’s largest treatment providers for individuals diagnosed with autism spectrum disorder. Prior to filing for Chapter 11, CARD entered into a stalking horse asset purchase agreement for a going-concern sale of substantially all of CARD’s assets. CARD intends to use the Chapter 11 cases to run a competitive sale and bidding process to maximize enterprise value. CARD entered the Chapter 11 cases with a new money, delayed draw term loan debtor-in-possession financing facility from the company’s prepetition credit facility lenders
• Envision Healthcare Corp. and 216 of its affiliates in the commencement of pre-arranged Chapter 11 cases. Envision is a leading national medical group that employs or partners with more than 21,000 clinicians and provides care to patients across the U.S., with nearly 30 million patient visits each year. The two restructuring support agreements contemplate a collective deleveraging of approximately $7.4 billion of secured and unsecured debt and the separation of Envision’s physician services and ambulatory surgical center businesses